INSIGHTS ON PHARMACEUTICAL INSPECTION
-
Enhanced Flow Kit Performance With Leak And PUPSIT Testing
Sterile drug filtration demands rigorous integrity testing to prevent contamination. Learn how PUPSIT and in situ leak testing strengthen compliance with EU GMP Annex 1 and ensure reliable manufacturing.
-
M6 Tablet Metal Detector For Pharmaceutical And Nutraceutical Production
Ensure the safety and quality of your tablets and capsules with a metal detector designed for stability and high sensitivity in pharmaceutical and nutraceutical production.
-
A Closer Look At Multi-Lane Checkweighing In Pharma
Learn how multi-lane checkweighing boosts operational efficiency, ensures accurate dosing, and simplifies changeovers, making it ideal for applications like dual-chamber sachets and nutraceutical products.
-
Ensuring Integrity: A Comprehensive Approach To CCI
Deterministic CCI testing ensures compliance in packaging. Learn how advanced methods like Vacuum Decay, HVLD, and Helium Leak Detection deliver results aligned with USP 1207 and global standards.
-
Advanced Aseptic Filling Assembly Helium Integrity Testing10/15/2025
Helium leak testing offers unmatched sensitivity for detecting micro-leaks in single-use fill-finish systems. Learn how tighter leak thresholds can strengthen aseptic processing and regulatory confidence.
-
Advancing Drug Product Quality Through AVI And Future-Ready Infrastructure9/5/2025
Automated visual inspection (AVI) combines robotics, precision imaging, and sophisticated defect-recognition software to provide a scalable solution for expanding pipelines and rises in production volumes.
-
A Closer Look At Inspection Systems In Tablet And Capsule Production8/29/2024
Walk through the rigorous inspection process pharmaceutical products undergo to ensure safety and quality, from granulated ingredients to packaging.
-
Supporting GLP-1 And Peptides With Integrated Solutions9/30/2025
Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.
-
OEE And Product Inspection2/13/2025
Explore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.
PHARMACEUTICAL INSPECTION SOLUTIONS
-
The pharmaceutical industry continues to lead industries in terms of quality requirements and the value of data. The shift to more automated processes is less about the cost of human capital, but more about the pursuit of quality. The European Medicines Agency (EMA) updated Annex 1, driving for 100% inspection on fused containers and appropriate quality test measures for applications based on level of risk. The United States Pharmacopeia (USP) revamped Chapter 1207 on container closure integrity (CCI) to be prescriptive of deterministic technologies and encourages a deeper understanding of a container’s CCI requirements. The FDA continues to drive a ‘quality culture’ agenda versus a ‘compliance culture’, and the FDA has been explicitly targeting data integrity as a campaign for assuring quality. Every regulatory and guidance body is driving towards more reliable and accurate test methods.
-
The HDI Pinhole Inspector from Nikka Densok offers 100% inspection for BFS vial card production.
-
The Thermo Scientific Xpert X-ray Inspection System enables compliance with worldwide HACCP and retailer food safety requirements as well as offering X-ray image analysis for other critical quality verifications.
-
Pharmaceutical and biotechnology manufacturers must ensure the quality of materials - from incoming raw material through finished product.
-
Tyvek® gives the premium microbial barrier protection for sterilized medical instruments and pharmaceuticals. Apart from protecting the medical devices and pharmaceutical products from physical damages, medical and pharmaceutical packages also should provide an effective microbial barrier and help to maintain the sterility of the products. Bacteria and viruses with sizes varying from 0.002 to 100 microns are a constant threat to pharmaceuticals and medical devices which in turn can be hazardous to the patients.